Published in Clin Pharmacokinet on August 28, 1978
The role for N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.99
N-acetylcysteine as a potential antidote and biomonitoring agent of methylmercury exposure. Environ Health Perspect (2008) 0.86
N-acetylcysteine as an antidote in methylmercury poisoning. Environ Health Perspect (1998) 0.86
Chronic administration of N-acetylcysteine fails to prevent nitrate tolerance in patients with stable angina pectoris. Br J Clin Pharmacol (1990) 0.77
Measurement of lung volumes by plethysmography. Eur Respir J (1997) 2.08
Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med (1999) 1.73
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
A rapid gas chromatographic method for the determination of thiamphenicol in body fluids and tissues. J Chromatogr (1973) 1.47
Drug/polymer matrix swelling and dissolution. Pharm Res (1988) 1.40
Failure of body plethysmography in bronchial asthma. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.26
Public health and medicolegal implications of sleep apnoea. Eur Respir J (2002) 1.14
Acoustic analysis of snoring sound in patients with simple snoring and obstructive sleep apnoea. Eur Respir J (1996) 1.14
The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories. Eur Respir J (2011) 1.11
In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Control Release (2001) 1.08
Effects of vagal blockade on lung mechanics in normal man. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.08
Physical properties of parabens and their mixtures: solubility in water, thermal behavior, and crystal structures. J Pharm Sci (1999) 1.06
Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Respir Dis Suppl (1980) 1.01
Proposal for a systematic analysis of polygraphy or polysomnography for identifying and scoring abnormal events occurring during non-invasive ventilation. Thorax (2010) 1.00
Respiratory intermediate care units: a European survey. Eur Respir J (2002) 0.99
Dissecting aneurysm of the gastroduodenal artery: anatomic basis for the clinical syndrome of abdominal apoplexy. Ann Surg (1969) 0.97
Sex and age differences in intrathoracic airways mechanics in normal man. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.95
Mouth spraying versus inhalation of fenoterol aerosol in healthy subjects and asthmatic patients. Br J Dis Chest (1982) 0.95
Pulmonary function in patients with primary spontaneous pneumothorax. Bull Eur Physiopathol Respir (1979) 0.92
Reassessment of the interruption technique for measuring flow resistance in humans. J Appl Physiol (1985) (1989) 0.89
Bronchial asthma following exposure to ECG ink. Ann Allergy (1982) 0.89
Lecithin organogel as matrix for transdermal transport of drugs. J Pharm Sci (1992) 0.89
Head position modifies upper airway resistance in men. J Appl Physiol (1985) (1988) 0.88
[Demonstration, isolation and physical and chemical characteristics of narciclasine, a new antimitotic of plant origin]. Tumori (1968) 0.88
Epidermal growth factor in the topical treatment of traumatic corneal ulcers. Ophthalmologica (1993) 0.87
Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances. Eur J Pharm Sci (2004) 0.87
Influence of beta-2 agonist aerosols on pressure-volume characteristics of the lungs. Am Rev Respir Dis (1978) 0.86
Nasal obstruction and its impact on sleep-related breathing disorders. Rhinology (2005) 0.85
Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide. Eur J Pharm Sci (2001) 0.85
Esophageal-pericardial fistula presenting as pericarditis. Am Heart J (1983) 0.84
Thiamphenicol excretion in subjects with renal insufficiency. Int Z Klin Pharmakol Ther Toxikol (1970) 0.84
Elimination of chloramphenicol and thiamphenicol in subjects with cirrhosis of the liver. Int J Clin Pharmacol (1972) 0.84
Acoustic analysis of vowel emission in obstructive sleep apnea. Chest (1993) 0.83
Programmable biodegradable implants. J Control Release (2001) 0.83
Rotary tangential spray technique for aqueous film coating of indobufen pellets. Drug Dev Ind Pharm (1998) 0.83
Medico-legal implications of sleep apnoea syndrome: driving license regulations in Europe. Sleep Med (2007) 0.82
Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices. Biomaterials (2001) 0.82
Effective surface area and activity of antacid preparations. Farmaco Prat (1985) 0.82
Cross-linked sodium carboxymethylcellulose as a carrier for dissolution rate improvement of drugs. Boll Chim Farm (1990) 0.82
Swelling-activated drug delivery systems. Biomaterials (1988) 0.80
Thiamphenicol excretion in subjects with renal insufficiency. Int Z Klin Pharmakol Ther Toxikol (1970) 0.80
Effects of two inotropic drugs, dopamine and dobutamine, on pulmonary gas exchange in artificially ventilated patients. Intensive Care Med (1989) 0.80
Response of automatic continuous positive airway pressure devices in a normal subject. Eur Respir J (2011) 0.79
Monolithic triglyceride matrices: a controlled-release system for proteins. Pharm Dev Technol (2003) 0.79
Successful treatment of acute allograft failure using pneumatic biventricular assistance. J Heart Lung Transplant (1991) 0.79
Thiamphenicol elimination in renal insufficiency. Postgrad Med J (1974) 0.79
Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen. Arzneimittelforschung (1992) 0.78
Accelerated micro and ultramicro procedure for ornithine carbamyl-transferase (OCT) determination. Clin Chim Acta (1967) 0.78
Supramaximal flow in asthmatic patients. Eur Respir J (2002) 0.78
Hypopharyngeal and neck cross-sectional changes monitored by inductive plethysmography. J Appl Physiol (1985) (1990) 0.77
Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: an investigation into the mechanisms governing drug release. J Pharm Sci (2007) 0.77
Hysteresis of the alveolar capillary membrane in normal subjects. J Appl Physiol (1985) (1986) 0.77
Exercise-induced laryngospasm of emotional origin. Pediatr Pulmonol (1990) 0.77
Obstructive apneas during continuous positive airway pressure: unexpected finding with nasal pillow interface. Am J Respir Crit Care Med (2012) 0.77
Hyaluronidase-injectable microparticles intended for the treatment of extravasation. J Microencapsul (1998) 0.77
Multicenter open trial of cefotetan and cefoxitin in elective biliary surgery. Am J Surg (1988) 0.76
Epidermal growth factor in the topical treatment of herpetic corneal ulcers. Ophthalmologica (1994) 0.76
In vitro and in vivo evaluation of oral systems for time and site specific delivery of drugs (Chronotopic technology). Boll Chim Farm (1999) 0.76
Dopamine, dopaminergic drugs and ocular hypertension. Int Ophthalmol (1992) 0.76
Proceedings: Newer developments in chloramphenicol metabolism. Br J Pharmacol (1974) 0.75
OSA treatment UPPP vs N-CPAP. Chest (1995) 0.75
What is this thing called somnolence? Eur Respir J (2011) 0.75
Aluminum-magnesium antacids and the bioavailability of ketoscilium in man. Arzneimittelforschung (1979) 0.75
[Intrathoracic kidney (author's transl)]. Acta Chir Belg (1976) 0.75
Crystal forms of piroxicam pivalate: preparation and characterization of two polymorphs. J Pharm Sci (1998) 0.75
Structural characterization of two polymorphic forms of piroxicam pivalate. J Pharm Sci (1998) 0.75
Monolithic glyceryl trimyristate matrices for parenteral drug release applications. Eur J Pharm Biopharm (2003) 0.75
Extrusion-spheronisation of highly loaded 5-ASA multiparticulate dosage forms. Int J Pharm (2010) 0.75
[The use of cimetidine in renal insufficiency under hemodialytic treatment]. Minerva Nefrol (1981) 0.75
Ocular pharmacokinetics and pharmacodynamics in rabbits of ibopamine, a new mydriatic agent. Exp Eye Res (1993) 0.75
Simulation of the disintegration process of pharmaceutical tablets. Pharm Acta Helv (1988) 0.75
Ocular pharmacokinetics of thiamphenicol in rabbits. Arzneimittelforschung (1992) 0.75
[Bioadhesives: rationale, state of the art and therapeutic potential]. Boll Chim Farm (1995) 0.75
Distribution of khellin in excised human skin following iontophoresis and passive dermal transport. J Control Release (1999) 0.75
Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration. J Chromatogr (1989) 0.75
Identification of thiamphenicol excretion products in rat urine using gas-chromatography--mass-spectrometry. Postgrad Med J (1974) 0.75
Polymorphism of rac-5,6-diisobutyryloxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene hydrochloride (CHF 1035). I. Thermal, spectroscopic, and X-ray diffraction properties. J Pharm Sci (2001) 0.75
[Significance of serum ornithine carbamoyl-transferase (OCT) in the toxicological study of new drugs]. Boll Chim Farm (1972) 0.75
[Description of therapeutic systems using transmucosal absorption]. Boll Chim Farm (1984) 0.75
[Determination of some organ-specific enzymes: recent progress in methodology and diagnostic applications]. Ann Ist Super Sanita (1971) 0.75
Absorption of sodium diclofenac after ocular administration in rabbit. Arzneimittelforschung (1998) 0.75
Photometric evaluation of dye diffusion in the skin. J Pharm Pharmacol (1970) 0.75
[Ventilator modes and settings during non-invasive ventilation: effects on respiratory events and implications for their identification. 2011]. Rev Mal Respir (2013) 0.75
[Elimination of chloramphenicol and thiamphenicol in patients with liver cirrhosis]. Boll Chim Farm (1972) 0.75
[Biochemical and electrocardiographic evaluation of acetylcysteine in intravenous administration]. Clin Ter (1971) 0.75
A route to the total synthesis of iso-LTB4 system. Farmaco Sci (1985) 0.75
[Glucuroconjugation in vitro of chloramphenicol in normal rats and in rats pre-treated with phenobarbital]. Boll Chim Farm (1974) 0.75
[Excretion of thiamphenicol in subjects with renal insufficiency]. Boll Chim Farm (1970) 0.75
Senile cataractic lenses do not accumulate galactitol in either lactose tolerant or intolerant subjects. Clin Chim Acta (1993) 0.75
Active packaging for topical cosmetic/drug products: a hot-melt extruded preservative delivery device. Eur J Pharm Biopharm (2010) 0.75
Effect of partial hepatectomy and renal impairment of thiamphenicol metabolism in rats. Pharmacol Res Commun (1977) 0.75
Swelling-restricted minimatrices for controlled release of drugs. Preliminary in-vivo studies. Boll Chim Farm (1989) 0.75
Intrathoracic airway mechanics in patients with emphysema. Bull Eur Physiopathol Respir (1980) 0.75
A combat casualty course for increasing the operational readiness of reserve component health care professionals. Mil Med (1985) 0.75
Elastic properties of the lung in acute induced asthma. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.75
Optimisation and scale-up of a highly-loaded 5-ASA multi-particulate dosage form using a factorial approach. Eur J Pharm Sci (2011) 0.75
Increase of chloramphenicol glucuronidation in rats treated with phenobarbital. Biochem Pharmacol (1974) 0.75
Polymorphism of NCX4016, an NO-releasing derivative of acetylsalicylic acid. J Pharm Sci (2004) 0.75
A physiochemical approach to the investigation of the stability of trimethoprim-sulfamethoxazole (co-trimoxazole) mixtures for injectables. J Pharm Sci (1995) 0.75
The importance of the balloon reservoir volume of a CPAP system in reducing the work of breathing. Intensive Care Med (1986) 0.75